After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
In highlights from this week's trading diary and posts, Kass tells us about the good, the bad and the ugly.
Gilead (GILD) stock was downgraded to ‘hold’ at Argus this morning.
The company's hepatitis C drug division is expected to see losses in the second half of the year.
Some of this month's most explosive moves are coming from large-cap stocks. Here's how to profit from five of them.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.